These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 30395540)

  • 1. An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion.
    Klement JD; Paschall AV; Redd PS; Ibrahim ML; Lu C; Yang D; Celis E; Abrams SI; Ozato K; Liu K
    J Clin Invest; 2018 Dec; 128(12):5549-5560. PubMed ID: 30395540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WDR5-H3K4me3 epigenetic axis regulates OPN expression to compensate PD-L1 function to promote pancreatic cancer immune escape.
    Lu C; Liu Z; Klement JD; Yang D; Merting AD; Poschel D; Albers T; Waller JL; Shi H; Liu K
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34326167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin attenuates acute gastrointestinal graft-versus-host disease by preventing apoptosis of intestinal epithelial cells.
    Kawakami K; Minami N; Matsuura M; Iida T; Toyonaga T; Nagaishi K; Arimura Y; Fujimiya M; Uede T; Nakase H
    Biochem Biophys Res Commun; 2017 Apr; 485(2):468-475. PubMed ID: 28192120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IRF8: Mechanism of Action and Health Implications.
    Moorman HR; Reategui Y; Poschel DB; Liu K
    Cells; 2022 Aug; 11(17):. PubMed ID: 36078039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target.
    Wei J; Marisetty A; Schrand B; Gabrusiewicz K; Hashimoto Y; Ott M; Grami Z; Kong LY; Ling X; Caruso H; Zhou S; Wang YA; Fuller GN; Huse J; Gilboa E; Kang N; Huang X; Verhaak R; Li S; Heimberger AB
    J Clin Invest; 2019 Jan; 129(1):137-149. PubMed ID: 30307407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin controls immunosuppression in the tumor microenvironment.
    Shurin MR
    J Clin Invest; 2018 Dec; 128(12):5209-5212. PubMed ID: 30395537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade.
    Zhu Y; Yang J; Xu D; Gao XM; Zhang Z; Hsu JL; Li CW; Lim SO; Sheng YY; Zhang Y; Li JH; Luo Q; Zheng Y; Zhao Y; Lu L; Jia HL; Hung MC; Dong QZ; Qin LX
    Gut; 2019 Sep; 68(9):1653-1666. PubMed ID: 30902885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopontin Blockade Immunotherapy Increases Cytotoxic T Lymphocyte Lytic Activity and Suppresses Colon Tumor Progression.
    Klement JD; Poschel DB; Lu C; Merting AD; Yang D; Redd PS; Liu K
    Cancers (Basel); 2021 Feb; 13(5):. PubMed ID: 33670921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin modulates the generation of memory CD8+ T cells during influenza virus infection.
    Morimoto J; Sato K; Nakayama Y; Kimura C; Kajino K; Matsui Y; Miyazaki T; Uede T
    J Immunol; 2011 Dec; 187(11):5671-83. PubMed ID: 22021613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin shapes immunosuppression in the metastatic niche.
    Sangaletti S; Tripodo C; Sandri S; Torselli I; Vitali C; Ratti C; Botti L; Burocchi A; Porcasi R; Tomirotti A; Colombo MP; Chiodoni C
    Cancer Res; 2014 Sep; 74(17):4706-19. PubMed ID: 25035397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis.
    Murugaiyan G; Mittal A; Weiner HL
    J Immunol; 2008 Dec; 181(11):7480-8. PubMed ID: 19017937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MMP-9-cleaved osteopontin isoform mediates tumor immune escape by inducing expansion of myeloid-derived suppressor cells.
    Shao L; Zhang B; Wang L; Wu L; Kan Q; Fan K
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1478-1484. PubMed ID: 28986261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
    Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of osteopontin reduces alloreactive CD8+ T cell-mediated graft-versus-host disease.
    Zhao F; Zhang Y; Wang H; Jin M; He S; Shi Y; Guo Y; Zhang Y
    Blood; 2011 Feb; 117(5):1723-33. PubMed ID: 21119110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN regulatory factor 8 represses GM-CSF expression in T cells to affect myeloid cell lineage differentiation.
    Paschall AV; Zhang R; Qi CF; Bardhan K; Peng L; Lu G; Yang J; Merad M; McGaha T; Zhou G; Mellor A; Abrams SI; Morse HC; Ozato K; Xiong H; Liu K
    J Immunol; 2015 Mar; 194(5):2369-79. PubMed ID: 25646302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteopontin promotes host defense during Klebsiella pneumoniae-induced pneumonia.
    van der Windt GJ; Hoogerwerf JJ; de Vos AF; Florquin S; van der Poll T
    Eur Respir J; 2010 Dec; 36(6):1337-45. PubMed ID: 20378602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon Regulator Factor 8 (IRF8) Limits Ocular Pathology during HSV-1 Infection by Restraining the Activation and Expansion of CD8+ T Cells.
    Sun L; St Leger AJ; Yu CR; He C; Mahdi RM; Chan CC; Wang H; Morse HC; Egwuagu CE
    PLoS One; 2016; 11(5):e0155420. PubMed ID: 27171004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin increases hepatocellular carcinoma cell growth in a CD44 dependant manner.
    Phillips RJ; Helbig KJ; Van der Hoek KH; Seth D; Beard MR
    World J Gastroenterol; 2012 Jul; 18(26):3389-99. PubMed ID: 22807608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperative Immune-Mediated Mechanisms of the HDAC Inhibitor Entinostat, an IL15 Superagonist, and a Cancer Vaccine Effectively Synergize as a Novel Cancer Therapy.
    Hicks KC; Knudson KM; Lee KL; Hamilton DH; Hodge JW; Figg WD; Ordentlich P; Jones FR; Rabizadeh S; Soon-Shiong P; Schlom J; Gameiro SR
    Clin Cancer Res; 2020 Feb; 26(3):704-716. PubMed ID: 31645354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous blockade of multiple immune system inhibitory checkpoints enhances antitumor activity mediated by interleukin-15 in a murine metastatic colon carcinoma model.
    Yu P; Steel JC; Zhang M; Morris JC; Waldmann TA
    Clin Cancer Res; 2010 Dec; 16(24):6019-28. PubMed ID: 20924130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.